Cleared Abbreviated

K003920 - CORDIS M3 PTA DILATATION CATHETER

K003920 is an FDA 510(k) clearance for CORDIS M3 PTA DILATATION CATHETER, manufactured by Cordis Corp.. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Abbreviated 510(k) pathway after a 178-day FDA review.

K003920 · Cordis Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2001
Decision
178d
Days
Class 2
Risk

K003920 is an FDA 510(k) clearance for the CORDIS M3 PTA DILATATION CATHETER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Cordis Corp. (Warren, US). The FDA issued a Cleared decision on June 15, 2001 after a review of 178 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Cordis Corp. devices

FDA 510(k) Submission Details - K003920

510(k) Number K003920 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 19, 2000
Decision Date June 15, 2001
Days to Decision 178 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
53d slower than avg
Panel avg: 125d · This submission: 178d
Pathway characteristics
Standards-based clearance path.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 621
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K003920.
ATTAIN LDS 6216 LEFT-HEART DELIVERY SYSTEM
K012130 · Medtronic Vascular · Aug 2001
VIKING OPTIMA GUIDING CATHETER
K012002 · Guidant Corp. · Jul 2001
6F MACH 1, MODEL 34356-XXX
K010874 · Boston Scientific Corp · Jun 2001
AVIATOR PERIPHERAL DILATATION CATHETER
K010831 · Guidant Corp. · Jun 2001
CONCENTRIC RETRIEVER, MODEL 90030
K003410 · Concentric Medical, Inc. · May 2001
CONCENTROC HD GUIDE CATHETER, MODELS 90017 (4F), 90019 (5F), 90021 (6F), 90022 (7F), 90023 (8F), 90024 (9F)
K003880 · Concentric Medical, Inc. · May 2001